Skip to content

Drug interactions

Sorafenib + Thioridazine

Severity: Major

Sorafenib and Thioridazine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sorafenib can prolong the QT interval and thioridazine causes marked QTc prolongation. Together they raise the risk of torsades de pointes. Electrolyte disturbances such as diarrhea-related hypokalemia may add to the risk.

What this interaction means in plain words

Sorafenib and Thioridazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Sorafenib belongs to Oncology; Thioridazine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive prolongation of cardiac repolarization.

What to do

Avoid if possible and choose an antipsychotic with less QT effect. If used together, monitor ECG and electrolytes regularly.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sorafenib and Thioridazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sorafenib with Thioridazine?

MediHelp rates the interaction as major. Sorafenib and Thioridazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Sorafenib can prolong the QT interval and thioridazine causes marked QTc prolongation. Together they raise the risk of torsades de pointes. Electrolyte disturbances such as diarrhea-related hypokalemia may add to the risk.

How serious is the interaction between Sorafenib and Thioridazine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible and choose an antipsychotic with less QT effect. If used together, monitor ECG and electrolytes regularly.

What other medicines interact with Thioridazine?

MediHelp also lists interactions of Thioridazine with, for example, Abiraterone, Adagrasib, Amiodarone. The full list is on the Thioridazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in